0001566044-18-000011.txt : 20181212
0001566044-18-000011.hdr.sgml : 20181212
20181212184230
ACCESSION NUMBER: 0001566044-18-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181210
FILED AS OF DATE: 20181212
DATE AS OF CHANGE: 20181212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Basta Steven L
CENTRAL INDEX KEY: 0001417397
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38356
FILM NUMBER: 181231823
MAIL ADDRESS:
STREET 1: 1875 S GRANT STREET SUITE 110
CITY: SAN MATEO
STATE: CA
ZIP: 94402
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Menlo Therapeutics Inc.
CENTRAL INDEX KEY: 0001566044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 453757789
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 CARDINAL WAY, 2ND FLOOR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-486-1416
MAIL ADDRESS:
STREET 1: 200 CARDINAL WAY, 2ND FLOOR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER COMPANY:
FORMER CONFORMED NAME: Menlo Therapeutics, Inc.
DATE OF NAME CHANGE: 20170728
FORMER COMPANY:
FORMER CONFORMED NAME: Tigercat Pharma, Inc.
DATE OF NAME CHANGE: 20130104
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2018-12-10
0
0001566044
Menlo Therapeutics Inc.
MNLO
0001417397
Basta Steven L
200 CARDINAL WAY
2ND FLOOR
REDWOOD CITY
CA
94063
1
1
0
0
Chief Executive Officer
Stock Option
5.51
2018-12-10
4
A
0
141900
0.0
A
2028-12-10
Common Stock
141900
141900
D
The shares subject to the option will vest over a period of four years, with 1/48th of the shares subject to the option vesting monthly.
By: /s/ Kristine Ball, as attorney-in-fact For: Steven L Basta
2018-12-12